The table below shows ADMA BIOLOGICS, INC.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$114.49M
$134.22M
$121.98M
$114.80M
$119.84M
$107.19M
Cost of revenue
$33.74M
$58.60M
$54.76M
$53.70M
$60.18M
$49.74M
Gross profit
$80.75M
$75.63M
$67.23M
$61.10M
$59.66M
$57.45M
R&D
$2.60M
$1.53M
$1.03M
$826.00K
$412.00K
$560.00K
ADMA annual revenue (10-K history)
ADMA BIOLOGICS, INC. reported annual revenue of $510.17M for fiscal year 2025. That is up 19.6% from $426.45M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $10.66M (FY 2016) to $510.17M. Figures come from the company's audited annual reports as filed with the SEC.